RE:RE:CHINA TRIAL STATUS?Toniv,
As part of the
Hepalink deal, and as listed in Resverlogix corporate documents, "
Hepalink will be responsible for all clinical and development costs in the Territories, including a patient population that is expected to be included in the Company’s Phase 3 BETonMACE trial."
Most of the talk has been about Taiwan, however the Taiwan launch seems to keep getting pushed back. At the Q2 2016 update we were told that Taiwan BETonMACE involvement should be launching by end of 2016. At the December 2016 update we were told that Taiwan will begin recruiting in Q1 2017. The latest Zacks report listed that BETonMACE study sites in Taiwan, China and Russia are anticipated to open in June. So it seems that Taiwan and other sites will come on board BETonMACE soon.
BearDownAZ